For instance, AGR3 had already been characterized as a novel potential biomarker both for breast cancer prognosis and early breast cancer detection [54], while AGR2 expression has been correlated with poor outcomes of patients with ER-positive breast cancer [55]. Here, AGR3 is linked to breast carcinoma.